Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II study (Q46130238)
Jump to navigation
Jump to search
scientific article published on 25 April 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II study |
scientific article published on 25 April 2014 |
Statements
1 reference
Frontline bortezomib and rituximab for the treatment of newly diagnosed high tumour burden indolent non-Hodgkin lymphoma: a multicentre phase II study (English)
1 reference
1 reference
1 reference
Izidore S Lossos
1 reference
Irene Helenowski
1 reference
Michael Millenson
1 reference
Steve T Rosen
1 reference
25 April 2014
1 reference
166
1 reference
4
1 reference
514-520
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference